Current Value
US$ 7,62
Market Cap
US$ 9,37 M
VARIATION (12M)
-7,97%
VARIATION (60M)
-52,02%
DY
0,78%
graph

PILL PRICE

BVMF
PILL
If you had invested
If you had invested
year ago
year ago
6 months
1 year
5 years
10 years
today you would have
today you would have:

profitability of PILL

1 month
3 months
1 year
2 years
5 years
10 years
profitability
1 month
26,79%
3 months
45,14%
1 year
-7,97%
2 years
-19,45%
5 years
-52,02%
10 years
0,00%

real profitability

profitability minus inflation.

1 month
26,79%
3 months
44,42%
1 year
-12,56%
2 years
-26,58%
5 years
-64,94%
10 years
0,00%
Cotação

COMPARISON OF PILL WITH INDEXES

If you had invested R$ 1,000.00 (change) year ago 5 years, today you would have:

*The figure considers the reinvestment of dividends.
Cotação

Dividend History Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Current DY: 0,78%

5-year average DY: 0,95%

DRAG THE FRAME TO SEE MORE DATA

type

date with

payment date

value

Dividendos 25/03/2025 01/04/2025 0,01800000
Dividendos 23/12/2024 31/12/2024 0,01300000
Dividendos 24/09/2024 01/10/2024 0,02872000
Dividendos 25/06/2024 02/07/2024 0,02194000
Dividendos 20/03/2024 26/03/2024 0,02716000
Dividendos 22/12/2023 29/12/2023 0,03825000
Dividendos 20/09/2023 26/09/2023 0,03531000
Dividendos 22/06/2023 28/06/2023 0,04923000
Dividendos 22/03/2023 28/03/2023 0,01911000
Dividendos 21/12/2022 28/12/2022 0,03171000
Dividendos 21/09/2022 27/09/2022 0,01673000
Dividendos 23/06/2022 29/06/2022 0,00361000
Dividendos 23/03/2022 29/03/2022 0,00817000
Dividendos 22/12/2021 29/12/2021 0,00007000
Dividendos 24/12/2019 31/12/2019 0,00033000
Dividendos 25/09/2019 01/10/2019 0,01443000
Dividendos 26/06/2019 02/07/2019 0,02237000
Dividendos 20/03/2019 26/03/2019 0,05733000
Dividendos 28/12/2018 04/01/2019 0,09858000
Dividendos 26/09/2018 02/10/2018 0,04338000
Dividendos 20/06/2018 26/06/2018 0,05228000
Dividendos 20/12/2017 27/12/2017 0,01351000

ABOUT THE

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Average user rating I10

4.0 (1 people)

Common Questions

What is the price of PILL today?

The price of PILL today is R$ 41,45, with a variation of -7.97% compared to the last year. The price of PILL started the year trading around R$ 38,62 and today it is at R$ 41,45. Follow the chart of real-time price, the historical price of PILL, and all information about this ETF.

PILL is it worth it?

Currently, PILL is priced at R$ 41,45 and has a market capitalization of approximately R$ 50.971.722,88. In the last year, the ETF recorded a return of -43,36%, considering only the variation of the share.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of PILL?

Investing in PILL can be done in two ways: through B3, if the ETF is traded in Brazil, or through a brokerage with access to the international market, if it is an ETF.

If PILL is listed on B3, just have an account with a Brazilian brokerage, access the home broker, search for the ETF ticker, and place your order. by the ticker, define the quantity, and send the purchase order.

If it is an international ETF, you need to open an account with a brokerage that offers access to the US market or a foreign ETF. of other exchanges. In this case, the investment will be made in dollars, and the order must be sent directly through the brokerage system.

In some cases, it is also possible to invest in the international ETF through an ETF BDR, which is traded on B3 in reais and can be accessed by any Brazilian brokerage.

How much do 100 shares of PILL yield today?

The yield of PILL was 145,74% in the last month and -43,36% in the last year.

If you wanted to buy 100 shares of PILL today, the total investment would be based on the current price of R$ 41,45.

If past performance were to repeat, the return on your investment would be:

  • In 1 month: R$ 5.255,80
  • In 1 year: R$ 3.814,90
  • In 2 years: R$ 3.339,02

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.